Add like
Add dislike
Add to saved papers

The relation of pituitary adenomas invasiveness and the proliferative index measured by immunoexpression of topoisomerase IIα.

Endokrynologia Polska 2018 August 4
INTRODUCTION: Cavernous sinus invasion by pituitary adenoma affects surgical procedure radicality, and consequently the postoperative course and prognosis in pituitary adenomas treatment. The search for pituitary adenoma aggressive behaviour markers is still a matter of debate.

MATERIAL AND METHODS: This study evaluates the relation of pituitary adenoma invasiveness to the expression of topoisomerase IIα in 72 patients who underwent transsphenoidal pituitary surgery. The assessment of tumour growth was conducted according to the Hardy scale as modified by Wilson and the Knosp scale. Topoisomerase IIα expression in tumours specimens was evaluated using immunohistochemical staining.

RESULTS: There was a correlation between the Knosp scale degree and the topoisomerase IIα expression (Spearman R=0.3611, p<0.005). The Kruskal-Wallis H test (p=0.0034) showed that there was a statistically significant topoisomerase IIα expression increase in tumours classified as grade E on the Hardy scale. The topoisomerase IIα expression correlated also with tumour size (Spearman R=0.4117, p<0.001). Higher levels of expression were observed in macroadenomas, as compared to microadenomas (p<0.05, Mann-Whitney test). Topoisomerase IIα expression correlated with cavernous sinus invasion.

CONCLUSIONS: The topoisomerase IIα expression correlated more with invasiveness than with extensiveness, which might make it an eminently useful marker in the assessment of aggressive pituitary adenoma behaviour.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app